| Literature DB >> 33129829 |
Rachael S Allen1, Amber Douglass2, Harrison Vo2, Andrew J Feola3.
Abstract
Glaucoma is the leading cause of irreversible blindness worldwide, and women represent roughly 60% of the affected population. Early menopause and estrogen signaling defects are risk factors for glaucoma. Recently, we found that surgical menopause exacerbated visual dysfunction in an ocular hypertension model of glaucoma. Here, we investigated if surgical menopause exacerbated visual dysfunction in a model of direct retinal ganglion cell (RGC) damage via optic nerve crush (ONC). Female Long Evans rats (n = 12) underwent ovariectomy (OVX) to induce surgical menopause or Sham surgery. Eight weeks post-surgery, baseline visual function was assessed via optomotor response. Afterwards, rats underwent monocular ONC. Visual function was assessed at 4, 8, and 12 weeks post-ONC. At 12 weeks, retinal function via electroretinography and retinal nerve fiber layer (RNFL) thickness via optical coherence tomography were measured. Visual acuity was reduced after ONC (p < 0.001), with surgical menopausal animals having 31.7% lower visual acuity than Sham animals at 12 weeks (p = 0.01). RNFL thinning (p < 0.0001) and decreased RGC function (p = 0.0016) occurred at 12 weeks in ONC groups. Surgical menopause worsens visual acuity after direct RGC damage using an ONC model. This demonstrates that surgical menopause plays a role in visual function after injury. Published by Elsevier Ltd.Entities:
Keywords: Estrogen; Glaucoma; Menopause; Optic nerve crush; Ovariectomy; Visual function
Mesh:
Year: 2020 PMID: 33129829 PMCID: PMC7855931 DOI: 10.1016/j.exer.2020.108333
Source DB: PubMed Journal: Exp Eye Res ISSN: 0014-4835 Impact factor: 3.467